Evaxion A (EVAX) Liabilities and Shareholders Equity (2019 - 2026)

Evaxion A (EVAX) reported Liabilities and Shareholders Equity of $23.6 million for Q1 2026, down 6.33% on a YoY basis from $25.2 million in Q1 2025, and down 16.78% quarter-over-quarter from $28.4 million in Q4 2025.

Evaxion A (EVAX) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Evaxion A has reported Liabilities and Shareholders Equity for 8 years, with the latest figure at $23.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 6.33% year-over-year to $23.6 million; the trailing twelve-month figure through Mar 2026 stood at $104.2 million (up 96.84% YoY), and the FY2025 full-year result was $28.4 million, up 127.54% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $23.6 million, down from $28.4 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $41.1 million in Q1 2022, with the low at $22654.0 in Q1 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $21.5 million across 5 years, with a median of $22.2 million in 2022.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity sank 99.89% — and 2025, when it jumped 111310.79%.
  • Evaxion A's Liabilities and Shareholders Equity stood at $22.0 million in 2022, then sank by 41.48% to $12.9 million in 2023, then fell by 3.13% to $12.5 million in 2024, then jumped by 127.54% to $28.4 million in 2025, then dropped by 16.78% to $23.6 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $23.6 million (Q1 2026), $28.4 million (Q4 2025), and $29.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 40.87 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.64 Mn
Dec 31, 2025 28.41 Mn
Sep 30, 2025 29.74 Mn
Jun 30, 2025 22.45 Mn
Mar 31, 2025 25.24 Mn
Dec 31, 2024 12.49 Mn
Jun 30, 2024 15.23 Mn
Mar 31, 2024 22,654.00
Dec 31, 2023 12.89 Mn
Sep 30, 2023 11.94 Mn
Jun 30, 2023 16.75 Mn
Mar 31, 2023 20.49 Mn
Dec 31, 2022 22.03 Mn
Sep 30, 2022 27.45 Mn
Jun 30, 2022 34.00 Mn
Mar 31, 2022 41.08 Mn
Dec 31, 2021 40.16 Mn
Sep 30, 2021 24.12 Mn
Jun 30, 2021 27.66 Mn
Mar 31, 2021 34.92 Mn